This product includes the webinar and SAM credit.


Description:

This webinar will review the most recent revision of the World Health Organization (WHO) classification of acute leukemia with a particular focus on acute myeloid leukemia. A summary of changes to the classification of lymphoblastic leukemia/lymphoma and acute leukemias of ambiguous lineage will also be summarized.

A collaborative educational event presented by Association for Molecular Pathology (AMP) and Society for Hematopathology (SH).


Speaker: Daniel A. Arber, MD

Host: Mark D. Ewalt, MD

Duration: 1 hr

Level of Instruction: Intermediate

Last day to purchase course and claim credit: January 22, 2021

Maxiumum SAM credit available: 1.0


How to claim credit: To earn SAM credit, all learners must watch the webinar, achieve a minimum score of 80% on the online quiz, and complete an online survey. To access the quiz, click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left and then "submit credit" for the appropriate course.

This course is approved by the American Board of Pathology for 1.0 SAM credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online modular exams (answering at least 80% of the questions in a topic module correctly).

* You may not submit SAMs and CME/CMLE credit for the same content.


You may also be interested in:

 

Note: Join the AMP Family to purchase this content for a deep discount!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

 

 

Course Information
Course Date:
January 22, 2018
Course Objectives
  • Distinguish genetic mutations that define disease entities versus prognostic markers in acute leukemia.
  • Describe genetic abnormalities that define new disease categories of acute leukemia.
  • Apply diagnostic criteria for acute leukemia using a combination of clinical information, morphology, immunophenotyping and molecular genetic testing.
Update on the 2016 WHO Classification of Acute Leukemias
Speaker Information
Daniel A. Arber MD  [ view bio ]
Individual topic purchase: Selected
American Board of Pathology
Self-Assessment Module: 1.00
Products
Arber Presentation (+SAM)
AMP Regular Member: $0.00
AMP Technologist Member: $0.00
AMP Associate Member: $0.00
Non-member Price: $215.00